Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes
- PMID: 20485328
- PMCID: PMC3055642
- DOI: 10.1038/npp.2010.64
Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes
Abstract
There is shared genetic risk for dependence on multiple substances, and the nicotinic receptor gene cluster on chromosome 15 harbors multiple polymorphisms that associate to this risk. Here, we report the results of an association study with 21 SNPs genotyped across the CHRNA5, CHRNA3, and CHRNB4 loci on chromosome 15q25.1. The sample consists of a discovery set (N=1858) of European-American and African-American (AA) families, ascertained on the basis of a sibling pair with cocaine and/or opioid dependence, and a case-control replication sample (N=3388) collected for association studies of alcohol, cocaine, and opioid dependence. We tested the SNPs for association with lifetime cocaine, opioid, nicotine, and alcohol dependence. We replicated several previous findings, including associations between rs16969968 and nicotine dependence (P=0.002) and cocaine dependence (P=0.02), with opposite risk alleles for each substance. We observed these associations in AAs, which is a novel finding. The strongest association signal in either sample was between rs684513 in CHRNA5 and cocaine dependence (OR=1.43, P=0.0004) in the AA replication set. We also observed two SNPs associated with alcohol dependence, that is, rs615470 in CHRNA5 (OR=0.77, P=0.0006) and rs578776 (OR=0.78, P=0.001). The associations between CD and rs684513, AD and rs615470, and AD and rs578776 remained significant after a permutation-based correction for multiple testing. These data reinforce the importance of variation in the chromosome 15 nicotinic receptor subunit gene cluster for risk of dependence on multiple substances, although the direction of the effects may vary across substances.
Figures
Comment in
-
Risk gene variants for nicotine dependence: a success story in neuropsychiatric genetics with possible applications to drug development.Pharmacogenomics. 2010 Oct;11(10):1353-7. doi: 10.2217/pgs.10.144. Pharmacogenomics. 2010. PMID: 21047198 No abstract available.
References
-
- Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. - PubMed
-
- Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol. 1996;36:597–613. - PubMed
-
- Beutler E, Lichtman M, Coller BS, Kipps TJ, Seligsohn U.2001The sickle cell diseases and related disordersIn: Beutler E, Lichtman MA, Coller BS (eds).Williams Hematology6th edn.McGraw Hill: New York; 581–605.
-
- Bierut LJ, Dinwiddie SH, Begleiter H, Crowe RR, Hesselbrock V, Nurnberger JI, et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry. 1998;55:982–988. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA012690/DA/NIDA NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- K05 AA017435/AA/NIAAA NIH HHS/United States
- R01 DA018432/DA/NIDA NIH HHS/United States
- K24 DA022288/DA/NIDA NIH HHS/United States
- R01 AA011330/AA/NIAAA NIH HHS/United States
- K24 DA22288/DA/NIDA NIH HHS/United States
- R01 DA12690/DA/NIDA NIH HHS/United States
- K23 AA017689/AA/NIAAA NIH HHS/United States
- R01 AA11330/AA/NIAAA NIH HHS/United States
- R01 DA12849/DA/NIDA NIH HHS/United States
- M01 RR06192/RR/NCRR NIH HHS/United States
- K24 AA013736/AA/NIAAA NIH HHS/United States
- M01 RR006192/RR/NCRR NIH HHS/United States
- P50 AA12870/AA/NIAAA NIH HHS/United States
- P50 AA012870/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
